BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34498757)

  • 1.
    Shah R; Sehemby M; Garg R; Purandare N; Hira P; Mahajan A; Lele V; Malhotra G; Verma P; Rojekar A; Dalvi A; Uchino S; Rastogi S; Lila A; Patil V; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):190-199. PubMed ID: 34498757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4-based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience.
    Garg R; Shah R; Tiwari A; Purandare N; Lele VR; Malhotra G; Verma P; Gosavi V; Dalvi A; Kumar Jaiswal S; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2020 Dec; 93(6):678-686. PubMed ID: 32716527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-Exendin-4 PET/CT Detects Insulinomas in Patients With Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.
    Antwi K; Nicolas G; Fani M; Heye T; Pattou F; Grossman A; Chanson P; Reubi JC; Perren A; Gloor B; Vogt DR; Wild D; Christ E
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5843-5852. PubMed ID: 31298706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
    Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of three different molecular imaging methods in localization and grading of insulinoma.
    Chang L; Bi X; Li S; Tong Q; Gu Y; He Z; Li Y; Chen Q; Cui J; Yu H; He Q; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1163176. PubMed ID: 37455905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
    J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hitherto unknown brain meningioma detected on
    Parghane RV; Talole S; Basu S
    World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
    Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.
    Eriksson O; Velikyan I; Selvaraju RK; Kandeel F; Johansson L; Antoni G; Eriksson B; Sörensen J; Korsgren O
    J Clin Endocrinol Metab; 2014 May; 99(5):1519-24. PubMed ID: 24512490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.
    Shah R; Garg R; Majmundar M; Purandare N; Malhotra G; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):354-364. PubMed ID: 33386617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings.
    Pang Y; Meng T; Shang Q; Chen Z; Chen H
    Clin Nucl Med; 2022 Mar; 47(3):265-267. PubMed ID: 34507334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.
    Nockel P; Babic B; Millo C; Herscovitch P; Patel D; Nilubol N; Sadowski SM; Cochran C; Gorden P; Kebebew E
    J Clin Endocrinol Metab; 2017 Jan; 102(1):195-199. PubMed ID: 27805844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of ⁶⁸Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET).
    Albanus DR; Apitzsch J; Erdem Z; Erdem O; Verburg FA; Behrendt FF; Mottaghy FM; Heinzel A
    Eur J Radiol; 2015 Oct; 84(10):1866-72. PubMed ID: 26152870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors.
    Apitzsch J; Verburg FA; Mottaghy F; Heinzel A
    Diagn Interv Radiol; 2021 Jul; 27(4):573-579. PubMed ID: 34313245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(68)Ga-exendin-4 PET-CT for the localization of occult insulinomas: a prospective cohort study].
    Luo YP; Pan QQ; Li F; Yu M; Xing XP; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):837-842. PubMed ID: 30392304
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumors.
    Wong KK; Frey KA; Niedbala J; Kaza RK; Worden FP; Fitzpatrick KJ; Dewaraja YK
    Nucl Med Commun; 2022 Aug; 43(8):892-900. PubMed ID: 35703269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.